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Twenty years ago, podoconiosis was hidden in the bookshelves
and the suffering of people with the disease was a private mat-
ter that was not dealt with by the formal heath sector.1 For
many health workers in endemic countries, podoconiosis was a
mystifying dead end.2 However, with improved research, advo-
cacy and demonstration projects, the disease came out of the
‘Dark Age’.1 Podoconiosis, which causes massive swelling of the
lower leg, is caused by exposure to particles common in soils of
volcanic origin3 and is second only to lymphatic ﬁlariasis as the
leading cause of tropical lymphoedema.4 An estimated 4 million
people live with podoconiosis globally in 32 potentially endemic
countries.5 The control and elimination of podoconiosis rely on
consistent footwear use from an early age and regular foot
hygiene to avoid exposure to the type of soil responsible for the
disease.6 For those already affected by the disease, the main
strategy is hygiene-based management which includes foot
hygiene, foot care, wound care, compression, exercises, eleva-
tion of the legs and treatment of acute infections.7
Today, podoconiosis is a disease of signiﬁcant clinical and
public health importance in several endemic countries. Over the
last 15 years there has been remarkable progress in research,
advocacy and implementation of podoconiosis inteventions.1 In
2011 the World Health Organization (WHO) recognized podoco-
niosis as one of the neglected tropical diseases (NTDs) under
the category of ‘other tropical conditions’.8 Subsequently
Ethiopia, Rwanda and Cameroon recognized podoconiosis as a
priority NTD and included it in their long-term health plans.6
Mapping of podoconiosis has been completed in Cameroon,
Ethiopia and Rwanda and evidence supporting the effectiveness
of hygiene-based morbidity management has been estab-
lished.7 As a consequence, morbidity management services
have been integrated within the national health system in some
countries such as Ethiopia.9 Progress over recent years has been
impressive, but much remains to be done. There are several
remaining challenges ahead to be addressed.
First, there is the challenge of recognition of podoconiosis as
an important public health problem. The disease is one of the
most disabling tropical diseases and is linked to signiﬁcant stig-
ma, discrimination and comorbid mental health problems.10
The disease has a signiﬁcant impact in reducing the economic
productivity of affected individuals and their families.11 All these
justify the need for recognition of podoconiosis as a public
health challenge and the development of a comprehensive and
adequately resourced global health strategy towards elimin-
ation of podoconiosis. Advocacy is critical to increase awareness
of the disease by decision makers. Identifying public ﬁgures as
podoconiosis champions is important to achieve this goal. The
use of different media outlets, including social media and news-
letters, to increase public awareness is important. International
podoconiosis initiative should be at the forefront of these
efforts. The ﬁrst international conference on podoconiosis will be
held on 23 September 2018 in Addis Ababa, Ethiopia. The overall
theme for the conference is ‘Research to Implementation: A Call
for Global Action’. The conference should reach out to donors,
policymakers and programme planners.
Second, in the constantly changing global health architec-
ture, sustainable ﬁnancing of podoconiosis research and inter-
vention is a continuing challenge.6 Simple hygiene-based
management for the treatment of podoconiosis has been
shown to work. In a recent randomized controlled trial in
Ethiopia, the intervention reduced the incidence of acute der-
matolymphangioadenitis (one of the major sequela) by 20% in
those treated.7 Scaling up these interventions is critical to alle-
viate the suffering of people with podoconiosis and improve
their productivity and quality of life. Primary prevention inter-
ventions are also crucial. Empowering endemic communities
to use footwear and undertake proper foot hygiene is import-
ant. Proven health messaging approaches and addressing
practical and logistical challenges in accessing these inter-
ventions are needed.12 Sustainable ﬁnancing is required to
scale-up effective intervention. Donor funding for the scale-up
intervention is needed, but to sustain the delivery of interven-
tions it is critical to have domestic ﬁnancing by endemic country
governments.
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Third, accurate data on the global burden and distribution of
podoconiosis are critically required. As the former United
Nations Secretary-General Koﬁ Annan said recently, ‘Without
good data, we’re ﬂying blind. If you can’t see it, you can’t solve
it’.13 Investment in data generation for podoconiosis is a central
point. Only 3 of the 32 potentially endemic countries have
mapped the distribution of podoconiosis. Current global esti-
mates rely on expert opinion. These data are barely enough to
convince donors of the magnitude of the burden of podoconio-
sis for resource commitment or to provide ministries of health
and policymakers with requisite data to plan interventions.
Ethiopia is one of the countries in which podoconiosis has been
mapped. Through mapping, 345 endemic districts were identi-
ﬁed, an estimated 35 million people are at risk of the disease
and there are an estimated 1.5 million cases.14 This evidence
supported the initiation of a national podoconiosis program and
its integration in the national health system.15,16
Fourth, progress in the innovation of new tools for podoco-
niosis is required, as few tools have been identiﬁed or developed
for podoconiosis prevention and management. Right now is an
exciting time when comprehensive analysis of genetic,17 epi-
demiological and environmental information combined with
huge computational potential can be used to revolutionize
podoconiosis research and innovation. Such analysis will have a
two-pronged outcome: identifying the minerals responsible for
podoconiosis and guiding the development of diagnostic and
treatment tools by further increasing our understanding of the
genetics, immunology and pathophysiology of podoconiosis.
Innovations for the prevention of podoconiosis should also be
explored. Tools for personal protection from exposure to soil
should be developed. These tools should be acceptable, afford-
able and suit the speciﬁc context of people affected with podo-
coniosis and the environments they live in.
Fifth, translation of the evidence generated so far is needed.
Over the last two decades the focus has been on podoconiosis
research. Now it is time to translate the existing evidence into
actual practice. Until recently, implementation of podoconiosis
interventions was mainly by non-governmental organizations
and often on a small scale. Thus there is a need for the govern-
ments of endemic countries to scale-up interventions. Health
systems research focused on evaluation of the effectiveness of
interventions and delivery mechanisms should also be con-
ducted. Multidisciplinary and diverse research groups are
needed to accelerate the elimination of podoconiosis.
In order to continue to foster progress on podoconiosis elim-
ination, building on the gains so far is important to increase
funding for research and implementation. Domestic ﬁnancing of
interventions and funding from the international community for
research and development of new tools is important. Adoption
of podoconiosis as an important NTD by the World Health
Assembly is important to tackle the continuing challenge of
neglect. Going forward, a global strategy needs to be put in
place to tackle the issue of under implementation of podoconio-
sis programmes in endemic countries. This strategy, which could
be developed by the WHO, should offer clearer guidance on pro-
ven interventions and implementation approaches. Along these
lines, continued advocacy targeting bilateral donors and
endemic country governments should emphasize greater recog-
nition of podoconiosis as a disabling disease and a development
challenge for endemic countries. Advocacy to include podoco-
niosis in the Global Burden of Disease (GBD)18 estimation should
also be continued to generate robust global estimates that fur-
ther advance the goal of elimination and serve as a tool for fur-
ther evidence-based advocacy. The elimination of podoconiosis
is an important goal and is achievable. Nonetheless, advancing
this goal requires ﬁrm political commitment and sustainable pol-
icies. Endemic countries should have clear policies to address this
important problem. These include solutions for universal access
to affordable footwear, access to morbidity management ser-
vices and well-designed community engagement activities.
Finally, history tells us that unless we keep momentum going,
the gains achieved so far may be reversed. This is a clear reminder
that we must take action to address the unmet needs of people
with podoconiosis. Through targeted, evidence-based and cost-
effective interventions, we can ensure podoconiosis patients and
their families are afforded opportunities to realize their full poten-
tial. To achieve the elimination of podoconiosis, ﬁrm political will,
policy formulation and operational and ﬁnancial commitment are
needed from donors, bilateral and multilateral organizations and,
more importantly, endemic country governments.
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